Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Edward R. Garrity and Sangeeta Bhorade.

 
Connection Strength
 
 
 
3.653
 
  1. Bhorade S, Ahya VN, Baz MA, Valentine VG, Arcasoy SM, Love RB, Seethamraju H, Alex CG, Bag R, Deoliveira NC, Husain A, Vigneswaran WT, Charbeneau J, Krishnan JA, Durazo-Arvizu R, Norwick L, Garrity E. Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation. Am J Respir Crit Care Med. 2011 Feb 01; 183(3):379-87.
    View in: PubMed
    Score: 0.460
  2. Bhorade SM, Janata K, Vigneswaran WT, Alex CG, Garrity ER. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection. J Heart Lung Transplant. 2008 Sep; 27(9):990-4.
    View in: PubMed
    Score: 0.399
  3. Bhorade SM, Yu A, Vigneswaran WT, Alex CG, Garrity ER. Elevation of interleukin-15 protein expression in bronchoalveolar fluid in acute lung allograft rejection. Chest. 2007 Feb; 131(2):533-8.
    View in: PubMed
    Score: 0.358
  4. Bhorade SM, Villanueva J, Jordan A, Garrity ER. Immunosuppressive regimens in lung transplant recipients. Drugs Today (Barc). 2004 Dec; 40(12):1003-12.
    View in: PubMed
    Score: 0.308
  5. Bhorade SM, Jordan A, Villanueva J, Yu A, Kramer H, Vigneswaran WT, Garrity ER. Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation. Am J Transplant. 2003 Dec; 3(12):1570-5.
    View in: PubMed
    Score: 0.287
  6. Bhorade SM, Lurain NS, Jordan A, Leischner J, Villanueva J, Durazo R, Creech S, Vigneswaran WT, Garrity ER. Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients. J Heart Lung Transplant. 2002 Dec; 21(12):1274-82.
    View in: PubMed
    Score: 0.268
  7. Bhorade SM, Vigneswaran W, McCabe MA, Garrity ER. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant. 2000 Dec; 19(12):1199-204.
    View in: PubMed
    Score: 0.233
  8. Bhorade SM, Vigneswaran WT, Lanuza D, Garrity ER. Lung transplantation at Loyola University Medical Center. Clin Transpl. 1999; 281-8.
    View in: PubMed
    Score: 0.204
  9. Bhorade SM, Husain AN, Liao C, Li LC, Ahya VN, Baz MA, Valentine VG, Love RB, Seethamraju H, Alex CG, Bag R, DeOliveira NC, Vigneswaran WT, Garrity ER, Arcasoy SM. Interobserver variability in grading transbronchial lung biopsy specimens after lung transplantation. Chest. 2013 Jun; 143(6):1717-1724.
    View in: PubMed
    Score: 0.139
  10. Ghassemieh B, Ahya VN, Baz MA, Valentine VG, Arcasoy SM, Love RB, Seethamraju H, Alex CG, Bag R, DeOliveira NC, Vigneswaran WT, Charbeneau J, Garrity ER, Bhorade SM. Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in lung transplantation. J Heart Lung Transplant. 2013 Jul; 32(7):701-6.
    View in: PubMed
    Score: 0.138
  11. Ahya VN, McShane PJ, Baz MA, Valentine VG, Arcasoy SM, Love RB, Seethamraju H, Garrity E, Alex CG, Bag R, DeOliveira NC, Vigneswaran WT, Charbeneau J, Krishnan JA, Durazo-Arvizu R, Norwick L, Bhorade S. Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation. J Heart Lung Transplant. 2011 Feb; 30(2):175-81.
    View in: PubMed
    Score: 0.116
  12. Vigneswaran WT, Helenowski M, Bhorade SM, Lamounier F, Alex C, Garrity ER. Early readmission is a predictor of overall survival following isolated lung transplantation. Int Surg. 2010 Oct-Dec; 95(4):299-304.
    View in: PubMed
    Score: 0.115
  13. Bhorade SM, Chen H, Molinero L, Liao C, Garrity ER, Vigneswaran WT, Shilling R, Sperling A, Chong A, Alegre ML. Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Transplantation. 2010 Sep 15; 90(5):540-6.
    View in: PubMed
    Score: 0.115
  14. Vigneswaran WT, Bhorade S, Wolfe M, Pelletiere K, Garrity ER. Clinical pathway after lung transplantation shortens hospital length of stay without affecting outcome. Int Surg. 2007 Mar-Apr; 92(2):93-8.
    View in: PubMed
    Score: 0.090
  15. Lu BS, Yu AD, Zhu X, Garrity ER, Vigneswaran WT, Bhorade SM. Sequential gene expression profiling in lung transplant recipients with chronic rejection. Chest. 2006 Sep; 130(3):847-54.
    View in: PubMed
    Score: 0.087
  16. Bhorade SM, Sandesara C, Garrity ER, Vigneswaran WT, Norwick L, Alkan S, Husain AN, McCabe MA, Yeldandi V. Quantification of cytomegalovirus (CMV) viral load by the hybrid capture assay allows for early detection of CMV disease in lung transplant recipients. J Heart Lung Transplant. 2001 Sep; 20(9):928-34.
    View in: PubMed
    Score: 0.061
  17. Garrity ER, Villanueva J, Bhorade SM, Husain AN, Vigneswaran WT. Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody. Transplantation. 2001 Mar 27; 71(6):773-7.
    View in: PubMed
    Score: 0.060
  18. Lanuza DM, Lefaiver CA, McCabe MA, Farcas GA, Bhorade SM, Garrity ER. Functional status and medical complications during the first year post lung transplantation (LTX). J Heart Lung Transplant. 2001 Feb; 20(2):204.
    View in: PubMed
    Score: 0.059
  19. Villanueva J, Bhorade SM, Robinson JA, Husain AN, Garrity ER. Extracorporeal photopheresis for the treatment of lung allograft rejection. Ann Transplant. 2000; 5(3):44-7.
    View in: PubMed
    Score: 0.055
  20. Gordon IO, Bhorade S, Vigneswaran WT, Garrity ER, Husain AN. SaLUTaRy: survey of lung transplant rejection. J Heart Lung Transplant. 2012 Sep; 31(9):972-9.
    View in: PubMed
    Score: 0.033
  21. Floreth T, Stern E, Tu Y, Stern R, Garrity ER, Bhorade SM, White SR. Differentiated transplant derived airway epithelial cell cytokine secretion is not regulated by cyclosporine. Respir Res. 2011 Apr 10; 12:44.
    View in: PubMed
    Score: 0.030
  22. Lurain NS, Fox AM, Lichy HM, Bhorade SM, Ware CF, Huang DD, Kwan SP, Garrity ER, Chou S. Analysis of the human cytomegalovirus genomic region from UL146 through UL147A reveals sequence hypervariability, genotypic stability, and overlapping transcripts. Virol J. 2006 Jan 12; 3:4.
    View in: PubMed
    Score: 0.021
  23. Lurain NS, Bhorade SM, Pursell KJ, Avery RK, Yeldandi VV, Isada CM, Robert ES, Kohn DJ, Arens MQ, Garrity ER, Taege AJ, Mullen MG, Todd KM, Bremer JW, Yen-Lieberman B. Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients. J Infect Dis. 2002 Sep 15; 186(6):760-8.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.